These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33135261)

  • 1. Loading dose and efficacy of continuous or extended infusion of beta-lactams compared with intermittent administration in patients with critical illnesses: A subgroup meta-analysis and meta-regression analysis.
    Wu CC; Su YC; Wu KS; Wu TH; Yang CS
    J Clin Pharm Ther; 2021 Apr; 46(2):424-432. PubMed ID: 33135261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
    Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J
    Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged versus Intermittent Infusion of Antibiotics in Acute and Severe Infections: A Meta-analysis.
    Luo J; Liao J; Cai R; Liu J; Huang Z; Cheng Y; Yang Z; Liu Z
    Arch Iran Med; 2019 Oct; 22(10):612-626. PubMed ID: 31679364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.
    Lee YR; Miller PD; Alzghari SK; Blanco DD; Hager JD; Kuntz KS
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):155-170. PubMed ID: 29027128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.
    Vardakas KZ; Voulgaris GL; Maliaros A; Samonis G; Falagas ME
    Lancet Infect Dis; 2018 Jan; 18(1):108-120. PubMed ID: 29102324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis.
    Aboulatta L; Sugita H; Wakabayashi H; Noma H; Sasaki T
    Int J Infect Dis; 2020 Sep; 98():41-50. PubMed ID: 32535299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.
    Tamma PD; Putcha N; Suh YD; Van Arendonk KJ; Rinke ML
    BMC Infect Dis; 2011 Jun; 11():181. PubMed ID: 21696619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics.
    Roberts JA; Webb S; Paterson D; Ho KM; Lipman J
    Crit Care Med; 2009 Jun; 37(6):2071-8. PubMed ID: 19384201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J;
    Am J Respir Crit Care Med; 2015 Dec; 192(11):1298-305. PubMed ID: 26200166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis.
    Teo J; Liew Y; Lee W; Kwa AL
    Int J Antimicrob Agents; 2014 May; 43(5):403-11. PubMed ID: 24657044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials.
    Kondo Y; Ota K; Imura H; Hara N; Shime N
    J Intensive Care; 2020; 8():77. PubMed ID: 33042550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Udy AA; Paul SK; Lipman J; ;
    Crit Care Resusc; 2013 Sep; 15(3):179-85. PubMed ID: 23944203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous versus intermittent infusions of antibiotics for the treatment of infectious diseases: Meta-analysis and systematic review.
    Chen CH; Chen YM; Chang YJ; Wang SH; Chang CY; Yen HC
    Medicine (Baltimore); 2019 Mar; 98(10):e14632. PubMed ID: 30855448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews.
    Thabet P; Joshi A; MacDonald E; Hutton B; Cheng W; Stevens A; Kanji S
    PLoS One; 2021; 16(1):e0244966. PubMed ID: 33481817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.
    Chant C; Leung A; Friedrich JO
    Crit Care; 2013 Nov; 17(6):R279. PubMed ID: 24289230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
    Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
    Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.